PYXS - Pyxis Oncology to Participate in Two Upcoming Investment Conferences | Benzinga
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced its participation in two upcoming investment conferences.
On September 6, 2023, members of the Pyxis Oncology executive team will host in-person 1x1 meetings with investors during the 2023 Wells Fargo Healthcare Conference in Boston. To schedule a meeting, please reach out to your Wells Fargo representative or contact Investor Relations at IR@pyxisoncology.com.
On September 11, 2023, a pre-recorded presentation by Lara S. Sullivan, M.D., President and Chief Executive Officer, will be made available via webcast as part of the H.C. Wainwright 25th Annual Global Investment Conference beginning at 7:00 AM EST. In addition, the Pyxis Oncology executive team will host 1x1 meetings with investors via Zoom. To schedule a meeting, please reach out to your H.C. Wainwright representative or contact Investor Relations.
For additional information on Pyxis Oncology, please visit pyxisoncology.com.
About Pyxis Oncology, Inc.
Pyxis Oncology, Inc. is a clinical stage company focused on defeating difficult-to-treat cancers. The company is efficiently building next-generation therapeutics ...